
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dysregulation of the mevalonate pathway during SARS‐CoV‐2 infection: An in silico study
Juan Luis Gomez Marti, Alan Wells, Adam Brufsky
Journal of Medical Virology (2020) Vol. 93, Iss. 4, pp. 2396-2405
Open Access | Times Cited: 16
Juan Luis Gomez Marti, Alan Wells, Adam Brufsky
Journal of Medical Virology (2020) Vol. 93, Iss. 4, pp. 2396-2405
Open Access | Times Cited: 16
Showing 16 citing articles:
Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology
Samira M. Hamed, Walid F. Elkhatib, Ahmed S. Khairalla, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Samira M. Hamed, Walid F. Elkhatib, Ahmed S. Khairalla, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 94
Cholesterol and COVID-19—therapeutic opportunities at the host/virus interface during cell entry
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 9
Thomas Grewal, Mai Khanh Linh Nguyen, Christa Buechler
Life Science Alliance (2024) Vol. 7, Iss. 5, pp. e202302453-e202302453
Open Access | Times Cited: 9
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Untargeted analysis in post-COVID-19 patients reveals dysregulated lipid pathways two years after recovery
Yamilé López‐Hernández, Juan José Oropeza-Valdez, David Alejandro García Lopez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Yamilé López‐Hernández, Juan José Oropeza-Valdez, David Alejandro García Lopez, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 17
Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls
Mark Woollam, Paula Angarita-Rivera, Amanda P. Siegel, et al.
Journal of Breath Research (2022) Vol. 16, Iss. 3, pp. 036002-036002
Closed Access | Times Cited: 25
Mark Woollam, Paula Angarita-Rivera, Amanda P. Siegel, et al.
Journal of Breath Research (2022) Vol. 16, Iss. 3, pp. 036002-036002
Closed Access | Times Cited: 25
The Molecular Interplay between Human Coronaviruses and Autophagy
Ankit Shroff, Taras Y. Nazarko
Cells (2021) Vol. 10, Iss. 8, pp. 2022-2022
Open Access | Times Cited: 25
Ankit Shroff, Taras Y. Nazarko
Cells (2021) Vol. 10, Iss. 8, pp. 2022-2022
Open Access | Times Cited: 25
N6-Acetyl-L-Lysine and p-Cresol as Key Metabolites in the Pathogenesis of COVID-19 in Obese Patients
Nour Jalaleddine, Mahmood Yaseen Hachim, Hamza M. Al‐Hroub, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Nour Jalaleddine, Mahmood Yaseen Hachim, Hamza M. Al‐Hroub, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
T Helper 17 Response to Severe Acute Respiratory Syndrome Coronavirus 2: A Type of Immune Response with Possible Therapeutic Implications
Juan Camilo Sarmiento-Monroy, Rafael Parra‐Medina, Édgar Garavito, et al.
Viral Immunology (2021) Vol. 34, Iss. 3, pp. 190-200
Closed Access | Times Cited: 14
Juan Camilo Sarmiento-Monroy, Rafael Parra‐Medina, Édgar Garavito, et al.
Viral Immunology (2021) Vol. 34, Iss. 3, pp. 190-200
Closed Access | Times Cited: 14
Review on In Silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2
Yüksel Çetin, Şeyma Aydınlık, Ayşen Güngör, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 38, pp. 5925-5948
Closed Access | Times Cited: 7
Yüksel Çetin, Şeyma Aydınlık, Ayşen Güngör, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 38, pp. 5925-5948
Closed Access | Times Cited: 7
Transcriptional and Histochemical Signatures of Bone Marrow Mononuclear Cell-Mediated Resolution of Synovitis
Bruno Carvalho Menarim, Hossam El‐Sheikh Ali, Shavahn C. Loux, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 6
Bruno Carvalho Menarim, Hossam El‐Sheikh Ali, Shavahn C. Loux, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 6
Transcriptomic approaches in COVID-19: From infection to vaccines
Luiz Gustavo Gardinassi, Camila Oliveira Silva Souza, Davi Vinícius de Lima, et al.
Elsevier eBooks (2023), pp. 125-144
Closed Access | Times Cited: 2
Luiz Gustavo Gardinassi, Camila Oliveira Silva Souza, Davi Vinícius de Lima, et al.
Elsevier eBooks (2023), pp. 125-144
Closed Access | Times Cited: 2
Lipid metabolism indicators in patients with SARS-CoV-2 infection
Н. А. Конышко, L.I. Volynets, G. S. Konyshko
Infectious diseases News Opinions Training (2024) Vol. 13, Iss. 1, pp. 58-66
Open Access
Н. А. Конышко, L.I. Volynets, G. S. Konyshko
Infectious diseases News Opinions Training (2024) Vol. 13, Iss. 1, pp. 58-66
Open Access
Plasma of COVID-19 Patients Does Not Alter Electrical Resistance of Human Endothelial Blood-Brain Barrier In Vitro
Agnė Pociūtė, Karolina Kriaučiūnaitė, Aida Kaušylė, et al.
Function (2024) Vol. 5, Iss. 2
Open Access
Agnė Pociūtė, Karolina Kriaučiūnaitė, Aida Kaušylė, et al.
Function (2024) Vol. 5, Iss. 2
Open Access
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks
Mahsa Aghajani Mir
Infection Genetics and Evolution (2024) Vol. 122, pp. 105613-105613
Open Access
Mahsa Aghajani Mir
Infection Genetics and Evolution (2024) Vol. 122, pp. 105613-105613
Open Access
Considerations of the effects of commonly investigated drugs for COVID-19 in the cholesterol synthesis pathway
Juan Luis Gomez Marti, Adam Brufsky
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 8, pp. 947-952
Open Access | Times Cited: 2
Juan Luis Gomez Marti, Adam Brufsky
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 8, pp. 947-952
Open Access | Times Cited: 2
Plasma of COVID-19 patients does not alter electrical resistance of human endothelial blood-brain barrierin vitro
Agnė Pociūtė, Karolina Kriaučiūnaitė, Aida Kaušylė, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Agnė Pociūtė, Karolina Kriaučiūnaitė, Aida Kaušylė, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access